Genetic basis of resistance to fusidic acid in staphylococci.
Resistance to fusidic acid in Staphylococcus aureus often results from acquisition of the fusB determinant or from mutations in the gene (fusA) that encodes the drug target (elongation factor G). We now report further studies on the genetic basis of resistance to this antibiotic in the staphylococci. Two staphylococcal genes that encode proteins exhibiting ca. 45% identity with FusB conferred resistance to fusidic acid in S. aureus. One of these genes (designated fusC) was subsequently detected in all fusidic acid-resistant clinical strains of S. aureus tested that did not carry fusB or mutations in fusA, and in strains of S. intermedius. The other gene (designated fusD) is carried by S. saprophyticus, explaining the inherent resistance of this species to fusidic acid. Fusidic acid-resistant strains of S. lugdunensis harbored fusB. Thus, resistance to fusidic acid in clinical isolates of S. aureus and other staphylococcal species frequently results from expression of FusB-type proteins.
O'Neill
A J
AJ
Antimicrobial Research Centre and Institute of Molecular and Cellular Biology, University of Leeds, Leeds, UK.
McLaws
F
F
Kahlmeter
G
G
Henriksen
A S
AS
Chopra
I
I
D000595:Amino Acid Sequence; D001426:Bacterial Proteins / Q000235:genetics; D024881:Drug Resistance, Bacterial; D005672:Fusidic Acid / Q000494:pharmacology*; D008969:Molecular Sequence Data; D013210:Staphylococcus / Q000187:drug effects* / Q000235:genetics
D001426:Bacterial Proteins; C492443:FusB protein, Staphylococcus aureus; D005672:Fusidic Acid